AstraZeneca fails to dominate in its appeal to the European Court of Justice
AstraZeneca has lost its appeal in the European Court of Justice against the decision of the General Court to a fine of €52.5 million for abusive patent misuse. In 2010, the General Court ruled that...
View ArticleCMA starts competition law investigation into pharmaceutical sector
The Competition and Markets Authority has commenced an investigation into a suspected breach of competition law in the pharmaceutical sector. There are no further details yet as to who the new...
View Article
More Pages to Explore .....
